Corbus Pharmaceuticals (CRBP) News Today $16.08 -0.48 (-2.90%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Down 13.5% in OctoberCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) was the target of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 2,380,000 shares, a decline of 13.5% from the October 15th total of 2,750,000 shares. Approximately 20.2% of the shares of the company are short sold. Based on an average trading volume of 648,200 shares, the days-to-cover ratio is presently 3.7 days.November 16, 2024 | marketbeat.comWhat is HC Wainwright's Forecast for CRBP Q1 Earnings?Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Corbus Pharmaceuticals in a note issued to investors on Thursday, November 7th. HC Wainwright analyst A. Maldonado anticipates that the biopharmaceuticNovember 11, 2024 | marketbeat.comCorbus Pharmaceuticals (CRBP) Receives a Buy from RBC CapitalNovember 9, 2024 | markets.businessinsider.comCorbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors despite daily gainsNovember 9, 2024 | marketwatch.comWe're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn RateNovember 9, 2024 | finance.yahoo.comCorbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate UpdateNovember 8, 2024 | uk.finance.yahoo.comCorbus Pharmaceuticals Reports Q3 2024 Financial ResultsNovember 8, 2024 | markets.businessinsider.comCorbus Pharmaceuticals Reports Q3 2024 Financials and UpdatesNovember 8, 2024 | markets.businessinsider.comCorbus Pharmaceuticals presents new CRB-913 pre-clinical data at Obesity WeekNovember 5, 2024 | markets.businessinsider.comCorbus Pharmaceuticals' (CRBP) Outperform Rating Reaffirmed at WedbushWedbush reiterated an "outperform" rating and issued a $51.00 price target on shares of Corbus Pharmaceuticals in a research report on Monday.November 4, 2024 | marketbeat.comShort Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Grows By 5.8%Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totalling 2,750,000 shares, an increase of 5.8% from the September 30th total of 2,600,000 shares. Based on an average trading volume of 638,700 shares, the days-to-cover ratio is currently 4.3 days. Currently, 23.6% of the company's stock are short sold.October 31, 2024 | marketbeat.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of "Buy" from AnalystsCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) has been assigned an average recommendation of "Buy" from the eight brokerages that are currently covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating and one has assigned aOctober 30, 2024 | marketbeat.comCorbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation ConferenceOctober 29, 2024 | globenewswire.comCorbus Pharmaceuticals Holdings Inc. stock rises Thursday, still underperforms marketOctober 25, 2024 | marketwatch.comUp 174% in 2024, Is It Too Late to Buy This Breakout Biotech Stock?October 24, 2024 | msn.comOppenheimer Keeps Their Buy Rating on Corbus Pharmaceuticals (CRBP)October 22, 2024 | markets.businessinsider.comCorbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Crosses Below 50 Day Moving Average - What's Next?Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Passes Below 50 Day Moving Average - Here's WhyOctober 22, 2024 | marketbeat.comCorbus Pharmaceuticals (CRBP) Receives a Buy from Mizuho SecuritiesOctober 18, 2024 | markets.businessinsider.comCorbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)October 16, 2024 | globenewswire.comMillennium Management LLC Adjusts Stake in Corbus PharmaceuticalsOctober 16, 2024 | finance.yahoo.comShort Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Rises By 106.3%Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 2,600,000 shares, an increase of 106.3% from the September 15th total of 1,260,000 shares. Approximately 22.3% of the company's stock are sold short. Based on an average trading volume of 623,100 shares, the short-interest ratio is currently 4.2 days.October 11, 2024 | marketbeat.comMillennium Management LLC Has $10.94 Million Position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)Millennium Management LLC lessened its stake in shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) by 25.6% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 241,649 shares of the biopharmaceutical company's stock after sOctober 8, 2024 | marketbeat.comPoint72 Asset Management L.P. Reduces Stock Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)Point72 Asset Management L.P. lessened its holdings in shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) by 69.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,515 shareOctober 1, 2024 | marketbeat.comCheck Out Last Week's Big Insider Buying: Biotechs, Energy, and MoreSeptember 29, 2024 | 247wallst.comCorbus Pharmaceuticals to Participate in the BMO Capital Markets' Oncology SummitSeptember 26, 2024 | globenewswire.comCorbus Pharmaceuticals Holdings Inc.September 26, 2024 | wsj.com325,140 Shares in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Acquired by Darwin Global Management Ltd.Darwin Global Management Ltd. purchased a new stake in shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 325,140 shares of the biopharmaSeptember 26, 2024 | marketbeat.comCormorant Asset Management, Lp Buys 350,000 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) StockSeptember 25, 2024 | insidertrades.comCormorant Asset Management's Strategic Acquisition in Corbus PharmaceuticalsSeptember 24, 2024 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GB:GSK), Sonova Holding AG (Six Swiss: CH:SOON) and Corbus Pharmaceuticals (CRBP)September 24, 2024 | markets.businessinsider.comNovo Nordisk A/S (NOV.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comNasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' NowSeptember 24, 2024 | benzinga.comBuy Rating Affirmed for Corbus Pharmaceuticals on CRB-913’s Potential and Holistic Pipeline ValuationSeptember 24, 2024 | markets.businessinsider.comMizuho recommends buying Corbus following its drop post-Novo's obesity dataSeptember 24, 2024 | msn.comCorbus Pharmaceuticals (NASDAQ:CRBP) Earns "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $80.00 price objective on shares of Corbus Pharmaceuticals in a report on Monday.September 23, 2024 | marketbeat.comIntegral Health Asset Management LLC Invests $4.53 Million in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)Integral Health Asset Management LLC purchased a new position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 100,000 shares of the biopharmaceutSeptember 23, 2024 | marketbeat.comNovo Nordisk's Monlunabant Data Drags Stocks Of Smaller PlayersSeptember 20, 2024 | benzinga.comCorbus Pharmaceuticals (NASDAQ:CRBP) Given "Outperform" Rating at MizuhoMizuho reissued an "outperform" rating and issued a $74.00 price target on shares of Corbus Pharmaceuticals in a report on Friday.September 20, 2024 | marketbeat.comNovo Dives — And Corbus Crashes — After New Weight-Loss Drug Causes Neuropsychiatric EffectsSeptember 20, 2024 | investors.comBank of New York Mellon Corp Takes $1.37 Million Position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)Bank of New York Mellon Corp acquired a new position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 30,236 shares of the biopharmSeptember 20, 2024 | marketbeat.comAcadian Asset Management LLC Invests $716,000 in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)Acadian Asset Management LLC acquired a new position in shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 15,854 shares of the biopSeptember 18, 2024 | marketbeat.comCorbus Pharmaceuticals (NASDAQ:CRBP) Shares Down 2% Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Down 2%September 17, 2024 | marketbeat.comCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by TD Asset Management IncTD Asset Management Inc lifted its position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) by 92.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 40,800 shares of the biopharmaceutical company's stock afSeptember 14, 2024 | marketbeat.comClariVest Asset Management LLC Makes New $725,000 Investment in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)ClariVest Asset Management LLC bought a new position in shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 16,021 shares of the biopharmaceutical company's stock, valuedSeptember 13, 2024 | marketbeat.comCorbus Pharmaceuticals (NASDAQ:CRBP) Shares Gap Down to $56.28Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Gap Down to $56.28September 11, 2024 | marketbeat.comCorbus Pharmaceuticals (NASDAQ:CRBP) Shares Up 6.7%Corbus Pharmaceuticals (NASDAQ:CRBP) Trading 6.7% HigherSeptember 9, 2024 | marketbeat.com3 Crazy Stocks to Buy That Are Outperforming Nvidia in 2024September 8, 2024 | 247wallst.comCorbus Pharmaceuticals (NASDAQ:CRBP) Trading Down 3.5%Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Down 3.5%September 5, 2024 | marketbeat.comCorbus Pharmaceuticals to Present at the 2024 Cantor Global Health ConferenceSeptember 5, 2024 | finance.yahoo.comCorbus Pharmaceuticals (NASDAQ:CRBP) Shares Up 4.3%Corbus Pharmaceuticals (NASDAQ:CRBP) Trading 4.3% HigherAugust 30, 2024 | marketbeat.com Get Corbus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. CRBP Media Mentions By Week CRBP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRBP News Sentiment▼1.750.46▲Average Medical News Sentiment CRBP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRBP Articles This Week▼13▲CRBP Articles Average Week Get Corbus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TNXP News RLAY News ERAS News EOLS News PLRX News CRON News PRTA News REPL News AUTL News CRGX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRBP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRBP Stock Alerts